MedPath

A randomised controlled trial to examine the effectiveness of single-visit Scale and Polish treatment, delivered at different intervals, in maintaining or improving periodontal health of adult patients

Completed
Conditions
Gingival health
Oral Health
Registration Number
ISRCTN56889016
Lead Sponsor
The University of Manchester (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
300
Inclusion Criteria

Participants must:
1. Be male and female adult patients aged between 18 to 60 years of age who are registered at either of the two dental practices on the Wirral and who have had two dental examinations in the last three years and a scale and polish in the last 18 months
2. Have the ability to understand and provide informed consent
3. Be available for the full duration of the study
4. Have a minimum of 20 teeth excluding third molars and not wear a removable prosthetic appliance

Exclusion Criteria

Patients with the following characteristics will be excluded from the study:
1. Patients who in their GDP?s opinion require periodontal treatment other than a one visit scale and polish (this would normally equate to a Basic Periodontal Examination [BPE] score of more than two, i.e. three or four)
2. Patients with acute periodontal disease characterised by the presence of pain, purulent exudate, or severe tooth mobility requiring immediate treatment intervention
3. Patients with a history of rheumatic fever, valvular heart disease or any condition requiring premedication to prevent endocarditis
4. Patients with extensive caries (three or more decayed teeth, requiring more than one visit for restoration)
5. Patients with a removable prosthetic appliance, with the exception of an acrylic splint to prevent nocturnal bruxism
6. Patients with soft or hard tissue tumours of the oral cavity
7. Patients who are pregnant or lactating at the commencement of the trial
8. Patients who are receiving long-term antibiotic, oral steroidal (i.e. except inhalers), or non-steroidal anti-inflammatory drugs
9. Subjects with diabetes, haemophilia or any other medical condition requiring medical support and/or drug therapy that may interfere with the parameters being investigated
10. Involvement in any concurrent study, the nature of which may affect the parameters being investigated in this study
11. Patients who have been formally diagnosed with, and who are receiving treatment for, either Sjogren?s syndrome or a dry mouth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath